• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

向有遗传疾病风险的亲属发出警告的职责:遗传咨询师的临床经验。

Duty to warn at-risk relatives for genetic disease: genetic counselors' clinical experience.

作者信息

Dugan R Beth, Wiesner Georgia L, Juengst Eric T, O'Riordan Maryann, Matthews Anne L, Robin Nathaniel H

机构信息

Hutzel Hospital, Detroit, MI, USA.

出版信息

Am J Med Genet C Semin Med Genet. 2003 May 15;119C(1):27-34. doi: 10.1002/ajmg.c.10005.

DOI:10.1002/ajmg.c.10005
PMID:12704635
Abstract

When a patient refuses to inform relatives of their risk for genetic disease, the genetic healthcare professional is faced with conflicting ethical obligations. On one side of the issue is the obligation to respect and protect patients' right to privacy. On the other side is the obligation to prevent harm and promote the welfare of the family members, which suggests a responsibility to warn at-risk relatives, even without the patient's consent. In an effort to examine the actual clinical impact of this issue, we conducted a pilot study that explored genetic counselors' experience with this conflict. A survey was developed and made available to members of the National Society of Genetic Counselors. Questions were either multiple-choice responses or open-ended. Almost half of respondents (119/259; 46%) had had a patient refuse to notify an at-risk relative. The most commonly cited reasons for refusal were estranged family relationships, altering family dynamics, insurance discrimination, and employment discrimination, respectively. Of these 119 counselors, 24 (21%) reported that they seriously considered warning the at-risk relatives without patient consent, and one actually did disclose. Three factors consistently made the counselors less likely to disclose: their patient's potential emotional reaction, the relationship between the relative and patient, and the chance that the relative could be aware of the disease by another means. These results suggest that while the conflict is often encountered in clinical practice, it is rare that the situation remains unresolved to the extent that genetic counselors actually consider warning at-risk relatives. However, when the situation was encountered, the counselors in this study reported a lower rate of disclosure without consent than would have been anticipated based on previous studies that used hypothetical situations. It may be that counselors do not recognize a duty to warn at-risk relatives as integral to their role and professional obligations.

摘要

当患者拒绝将其患遗传病的风险告知亲属时,基因保健专业人员面临相互冲突的伦理义务。问题的一方面是尊重和保护患者隐私权的义务。另一方面是预防伤害和促进家庭成员福祉的义务,这意味着即使未经患者同意,也有责任警告有风险的亲属。为了研究这个问题的实际临床影响,我们进行了一项试点研究,探讨了基因咨询师在这种冲突中的经历。我们设计了一项调查,并提供给美国国家基因咨询师协会的成员。问题既有多项选择题,也有开放式问题。几乎一半的受访者(119/259;46%)曾遇到过患者拒绝通知有风险的亲属的情况。最常被提及的拒绝理由分别是家庭关系疏远、改变家庭动态、保险歧视和就业歧视。在这119名咨询师中,24名(21%)报告说他们认真考虑过在未经患者同意的情况下警告有风险的亲属,其中一名实际上进行了披露。有三个因素一直使咨询师不太可能进行披露:患者可能的情绪反应、亲属与患者之间的关系以及亲属可能通过其他方式知晓疾病的可能性。这些结果表明,虽然在临床实践中经常遇到这种冲突,但基因咨询师实际考虑警告有风险亲属的情况很少得不到解决。然而,当遇到这种情况时,本研究中的咨询师报告的未经同意进行披露的比例低于基于以往使用假设情况的研究所预期的比例。可能是咨询师没有认识到警告有风险亲属的义务是其角色和职业义务的一个组成部分。

相似文献

1
Duty to warn at-risk relatives for genetic disease: genetic counselors' clinical experience.向有遗传疾病风险的亲属发出警告的职责:遗传咨询师的临床经验。
Am J Med Genet C Semin Med Genet. 2003 May 15;119C(1):27-34. doi: 10.1002/ajmg.c.10005.
2
Israeli nurses and genetic information disclosure.以色列护士与基因信息披露。
Nurs Ethics. 2007 May;14(3):280-94. doi: 10.1177/0969733007075862.
3
A physician's duty to warn family members of genetic risks: limiting the importance of Tarasoff.医生向家庭成员告知基因风险的责任:限制塔萨夫法则的重要性。
J Biolaw Bus. 2003;6(1):28-38.
4
Ethical and clinical practice considerations for genetic counselors related to direct-to-consumer marketing of genetic tests.遗传咨询师在基因检测直接面向消费者营销方面的伦理与临床实践考量
Am J Med Genet C Semin Med Genet. 2006 Nov 15;142C(4):284-92, discussion 293. doi: 10.1002/ajmg.c.30110.
5
Medical Geneticists' duty to warn at-risk relatives for genetic disease.医学遗传学家向遗传病高危亲属发出警示的职责。
Am J Med Genet A. 2003 Jul 30;120A(3):374-80. doi: 10.1002/ajmg.a.20227.
6
[Beyond the diagnosis of a genetic disease, the question of informing the relatives].[除了对遗传病进行诊断之外,还有告知亲属的问题]
Ann Pharm Fr. 2009 Jan;67(1):20-4. doi: 10.1016/j.pharma.2008.10.011. Epub 2008 Dec 6.
7
[Information for family members with an increased risk for a genetic disease].[给患有遗传性疾病风险增加的家庭成员的信息]
Dtsch Med Wochenschr. 2006 Mar 17;131(11):573-6. doi: 10.1055/s-2006-933700.
8
Genomic torts: the law of the future -- the duty of physicians to disclose the presence of a genetic disease to the relatives of their patients with the disease.基因侵权行为:未来的法律——医生向患有基因疾病的患者亲属披露该疾病存在的义务。
Univ San Francisco Law Rev. 1997 Fall;32(1):105-37.
9
The duty to warn at-risk relatives-The experience of genetic counselors and medical geneticists.向有风险的亲属发出警告的义务——遗传咨询师和医学遗传学家的经验。
Am J Med Genet A. 2020 Feb;182(2):314-321. doi: 10.1002/ajmg.a.61425. Epub 2019 Dec 8.
10
What should the law say about disclosure of genetic information to relatives?法律对于向亲属披露基因信息应该作何规定?
J Health Care Law Policy. 1998;1(2):373-90.

引用本文的文献

1
Health professionals contacting patients' relatives directly about genetic risk (with patient consent): current clinical practice and perspectives.在获得患者同意的情况下,医疗专业人员直接联系患者亲属告知基因风险:当前临床实践与观点。
Eur J Hum Genet. 2025 Apr;33(4):476-484. doi: 10.1038/s41431-024-01730-8. Epub 2024 Dec 19.
2
Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices.重视药品和其他卫生技术的社会影响:当前最佳实践用户指南。
Forum Health Econ Policy. 2024 Nov 8;27(1):29-116. doi: 10.1515/fhep-2024-0014. eCollection 2024 Jun 1.
3
Investigating genetic counselors' communication with Lynch syndrome patients about cascade testing: Barriers, facilitators, and strategies.
调查遗传咨询师与林奇综合征患者就级联检测进行沟通的情况:障碍、促进因素及策略。
J Genet Couns. 2025 Apr;34(2):e1937. doi: 10.1002/jgc4.1937. Epub 2024 Jul 4.
4
Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation.卫生系统主导的家族风险通知的可行性、可接受性及有限疗效:一项混合方法评估方案
Pilot Feasibility Stud. 2022 Aug 9;8(1):174. doi: 10.1186/s40814-022-01142-9.
5
The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives.先证者基因检测指征对亲属级联检测接受度的影响。
Front Genet. 2022 Jun 16;13:867226. doi: 10.3389/fgene.2022.867226. eCollection 2022.
6
Sharing information about domestic violence and abuse in healthcare: an analysis of English guidance and recommendations for good practice.分享医疗保健中关于家庭暴力和虐待的信息:对英国指导意见和良好实践建议的分析。
BMJ Open. 2022 Jun 16;12(6):e057022. doi: 10.1136/bmjopen-2021-057022.
7
Feasibility of a Traceback Approach for Using Pathology Specimens to Facilitate Genetic Testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study Protocol.在卵巢癌遗传风险分析(GRACE)研究方案中,利用病理标本采用追溯法促进基因检测的可行性。
J Pers Med. 2021 Nov 13;11(11):1194. doi: 10.3390/jpm11111194.
8
"Being proactive, not reactive": exploring perceptions of genetic testing among White, Latinx, and Pacific Islander Populations.“积极主动,而非被动应对”:探究白人群体、拉丁裔群体和太平洋岛民群体对基因检测的看法。
J Community Genet. 2021 Oct;12(4):617-630. doi: 10.1007/s12687-021-00542-3. Epub 2021 Aug 20.
9
Patient and Family Preferences on Health System-Led Direct Contact for Cascade Screening.患者及家属对卫生系统主导的级联筛查直接接触的偏好。
J Pers Med. 2021 Jun 10;11(6):538. doi: 10.3390/jpm11060538.
10
Physicians' Attitudes and Ethical Obligations to Pharmacogenetic Testing.医生对药物遗传学检测的态度及伦理义务
J Multidiscip Healthc. 2020 Mar 10;13:249-258. doi: 10.2147/JMDH.S245369. eCollection 2020.